Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000703147 | SCV000832033 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2024-01-16 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 532 of the DCTN1 protein (p.Arg532Gln). This variant is present in population databases (rs759306485, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DCTN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 579780). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DCTN1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV001091892 | SCV001248162 | uncertain significance | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001091892 | SCV004564574 | uncertain significance | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | The DCTN1 c.1595G>A; p.Arg532Gln variant (rs759306485), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 579780). This variant is found in the general population with an overall allele frequency of 0.001% (3/282,860 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.466). Due to limited information, the clinical significance of this variant is uncertain at this time. |
Ambry Genetics | RCV004026620 | SCV004854776 | uncertain significance | Inborn genetic diseases | 2023-10-14 | criteria provided, single submitter | clinical testing | The c.1595G>A (p.R532Q) alteration is located in exon 15 (coding exon 15) of the DCTN1 gene. This alteration results from a G to A substitution at nucleotide position 1595, causing the arginine (R) at amino acid position 532 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001091892 | SCV001951319 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001091892 | SCV001974173 | uncertain significance | not provided | no assertion criteria provided | clinical testing |